Press Releases
July 5, 2001
Swiss drug developer Debiopharm announces FDA approval of Trelstar TM LA for therapeutic use
June 7, 2001
New pharmaceutical development company in Quebec : The SGF and the Swiss Group Debio create H3 BioDé
May 19, 2001
Partenariat entre l’Ecole de Pharmacie Genève-Lausanne (EPGL) et Debiopharm Group™ – L’Université et l’Industrie allient leurs forces
April 14, 2001
Debiopharm and Aurigene sign agreement for the development and commercialisation of Debio 1142, a novel inhibitor of an undisclosed oncology…
February 13, 2001
Dyax Corp. and Debiopharm S.A. report initiation of phase II clinical trial with EPI-HNE-4 for cystic fibrosis
January 10, 2001
Swiss drug developer Debiopharm S.A. achieves another success in the development of molecules for theraeutic use